Dr. Sergio L. Faria, MD, PhD
Claim this profileMcGill University Health Centre-Cedars Cancer Centre
Studies Prostate Cancer
Studies Lung Cancer
4 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Sergio L. Faria, MD, PhD is currently running
SBRT
for Prostate Cancer
It is a phase I study of radical hypofractionation delivering one single fraction of SBRT in patients with low- and favorable intermediate-risk prostate cancer that will undergo placement of the SpaceOAR hydrogel prior to treatment. Our hypothesis is that treatments can be safely delivered in one single fraction using SBRT provided the separation between the prostate and rectum is increased using the hydrogel
Recruiting1 award N/A6 criteria
Hypofractionated Radiation Therapy + Eligard
for Prostate Cancer
Prostate cancer is the second most common cancer among Canadian men of which approximately 20-30% present with high-risk tumour characteristic. Although surgery can be curative in patients evidencing pathological high-risk disease (extracapsular extension, seminal vesicle involvement, positive surgical margins), a large proportion will develop biochemical failure within years from the surgical procedure. The failure rate is even more pronounced in those patients that present with high prostate specific antigen (PSA) levels, pT3 disease, positive margins and Gleason score ≥8 with an estimated 75% failure rate at 10 years. Post-operative radiotherapy (RT) has been shown in three randomized trials to significantly decrease the biochemical failure rate and in one of the trials a survival benefit was also seen with the addition of post-operative RT and is considered by many investigators standard therapy in patients with pathological high-risks factors even in absence of biochemical failure.
Recruiting2 awards Phase 210 criteria
More about Sergio L. Faria, MD, PhD
Clinical Trial Related7 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Sergio L. Faria, MD, PhD has experience with
- SBRT
- Eligard
- Postop Hypofractionated Radiation Therapy
- Chemoradiotherapy
- Chemoradiotherapy With Integrated Boost Dose
- Radical External Beam Radiotherapy
Breakdown of trials Sergio L. Faria, MD, PhD has run
Prostate Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sergio L. Faria, MD, PhD specialize in?
Sergio L. Faria, MD, PhD focuses on Prostate Cancer and Lung Cancer. In particular, much of their work with Prostate Cancer has involved treating patients, or patients who are undergoing treatment.
Is Sergio L. Faria, MD, PhD currently recruiting for clinical trials?
Yes, Sergio L. Faria, MD, PhD is currently recruiting for 3 clinical trials in Montréal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Sergio L. Faria, MD, PhD has studied deeply?
Yes, Sergio L. Faria, MD, PhD has studied treatments such as SBRT, Eligard, Postop Hypofractionated Radiation Therapy.
What is the best way to schedule an appointment with Sergio L. Faria, MD, PhD?
Apply for one of the trials that Sergio L. Faria, MD, PhD is conducting.
What is the office address of Sergio L. Faria, MD, PhD?
The office of Sergio L. Faria, MD, PhD is located at: McGill University Health Centre-Cedars Cancer Centre, Montréal, Quebec H4A 3J1 Canada. This is the address for their practice at the McGill University Health Centre-Cedars Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.